ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,653.00
12.50 (0.76%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  12.50 0.76% 1,653.00 1,654.00 1,655.00 1,655.50 1,634.00 1,638.50 3,990,601 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.83 68.14B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,640.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £68.14 billion. Gsk has a price to earnings ratio (PE ratio) of 13.83.

Gsk Share Discussion Threads

Showing 19176 to 19200 of 33100 messages
Chat Pages: Latest  772  771  770  769  768  767  766  765  764  763  762  761  Older
DateSubjectAuthorDiscuss
11/2/2019
18:56
Could well be right. The damned thing has been very volatile share price wise for a blue chip company. I like the divi...but I hate looking at red on my portfolio. Watching and waiting....
funtimejonny
11/2/2019
18:13
After ex div I bet below 1500p, 1465p my target.
montyhedge
11/2/2019
17:14
I agree. It's a bit pricey right now. I have it on me watchlist but not buying at this price
funtimejonny
11/2/2019
11:45
Emma...you on first name terms TM?

I do like your style. EMMA adds gravitas to your post.

Meanwhile GSK is falling..it does tend to disappoint circa £16.

Monty is right. Buy again sub £15.ex div.

Leave the dividend for the longs.


PS what is a green baseline?

zicopele
11/2/2019
11:33
The level and timing of GSK investments in Immuno-oncology is a strong indication that there's a massive opportunity here. Acquisition of Tesaro likely to tie in with the Merck partnership, and new R&D chief Hal Barron and Emma have it all planned with a faster track to the market than starting with a green baseline.
tradermichael
11/2/2019
10:59
A lot of hope and a lot of debt 20BN. GSK is not a corporate bond.

A little bad news on the deep science of Tesaro and there goes your yield.

zicopele
11/2/2019
10:48
monty: "because I know when ex div, they always fall,"

Not always, and always not for long if it does!

tradermichael
11/2/2019
10:46
I like the ord share, but even a great company bought at the wrong price is a bad investment, sold at 1560p foregoing the div, because I know when ex div, they always fall, I think I will get these back at 1465p.Shares of course should be quite firm leading up to ex div.
montyhedge
11/2/2019
09:29
All depends if you got in at the start, it was there 5.25% if your late to the party of course you won't get much.
montyhedge
11/2/2019
09:26
The 5.25% 2033 presumably redeems at 100 so are trading around 1/3rd higher than redemption price so yield to maturity is nowhere near 5.25%. Haven’t done the maths, but looks like it probably yields under 2% over the remaining life taking into account the redemption loss.
scburbs
11/2/2019
09:23
OK - as you know, there are plenty of peaks and troughs to sell and buy as this share swings and rarely goes anywhere in a straight line - good luck.
tradermichael
11/2/2019
09:13
I will stick around TM. want to buy back on the dips.

Should be lower at some stage in the next two weeks.

That debt of 20bn is a concern until it is not a concern

A Brexit deal might strengthen sterling and that will be bad. I presume all the longs on this board here are brexiteers

zicopele
11/2/2019
09:00
Goodbye zicopele - never thought this share suited you ;o)
tradermichael
11/2/2019
08:57
Thought you would have waited until ex d.
montyhedge
11/2/2019
08:36
Monty...I have sold...the debts are enormous.
zicopele
11/2/2019
08:08
Yes, but you can write the script now, until ex div they will be firm, go ex d then back below 1500p.
montyhedge
11/2/2019
08:07
GlaxoSmithKline (LON:GSK) had its target price increased by HSBC from GBX 1,820 ($23.78) to GBX 1,860 ($24.30) in a report released last Thursday. HSBC currently has a buy rating on the stock.
tradermichael
11/2/2019
07:43
The 5.25% 2033.
montyhedge
10/2/2019
13:38
Ex dividend dates for info if anyone timing exit
Thursday 21 February 2019
Thursday 16 May 2019
Thursday 8 August 2019
Thursday 14 November 2019
e&oe -

pugugly
10/2/2019
13:29
This is the sort of return you could expect from a GSK corporate bond. Personally, I like the 0% 2020 bonds! Nice to not have to worry about pesky dividends/interest.
scburbs
10/2/2019
13:25
Hit £22 in 1998.
jadeticl3
10/2/2019
12:55
??? £20+ around 20 years ago.
alphorn
10/2/2019
12:49
Wasn't the high in 2013, in the 1700s?
grahamite2
10/2/2019
07:10
Forget the divi (nats after tax), I'm in for return to the £20 days, bought at 14.84,not a lot, but rare (usually bear).
I'm influenced by the Co, I like it, but not in love. Business and all that.

Jump in, jump out - shake and roll.

dudishes
09/2/2019
15:39
You are exactly right, div 23p I bet they fall further than 23p when xd. GSK you know no dividend growth 80p for years to come it seems. Corporate bond for me.
montyhedge
Chat Pages: Latest  772  771  770  769  768  767  766  765  764  763  762  761  Older

Your Recent History

Delayed Upgrade Clock